Drug
Gadolinium DTPA clinical trials
Also written Magnevist and gadopentetate dimeglumine.
Includes 13 studies of Gadolinium ethoxybenzyl DTPA.
Keep track of what changes. Save the Gadolinium DTPA studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
22 studies that test it; most in 2003 (4)
| Year | Studies |
|---|---|
| 2003 | 4 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 10
Bayer (9) · Bracco Diagnostics, Inc (2) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Duke University (1) · Sara Varea (1) · University of Southern California (1) · Guerbet (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Gadolinium DTPA is read from its arms, and is right about nine times in ten.
Testing it · 22
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingPhase 4GuerbetNCT04373564Written as Gadoxetate disodium
- Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic MetastasesTerminatedPhase 4University of Colorado, DenverNCT04973007Written as Gadoxetate disodium
- Contrast-enhanced MRI in Detecting Benign and Malignant Liver LesionsActive, not recruitingNot applicableM.D. Anderson Cancer CenterNCT02156739Written as Gadoxetate Disodium
- Improving CBCT for Liver IG-SBRT Using Gadoxetate DisodiumWithdrawnPhase 4Slawa CwajnaNCT03215355Written as Primovist
- Multihance at 3 Tesla (3T) in Brain TumorsCompletedPhase 4Bracco Diagnostics, IncNCT00395863Written as Arm 2 - Magnevist
- Gadoxetate Enhanced Imaging Study to Detect Prostate CancerCompletedPhase 2National Cancer Institute (NCI)NCT01867424Written as Eovist
- Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate CancerStatus unknownEarly Phase 1University of CincinnatiNCT03960788Written as Gadoxetate Sodium
- Eovist vs. Dotarem Healthy Volunteer MRICompletedPhase 4Duke UniversityNCT02431598Written as gadoxetate disodium
- Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast AgentTerminatedPhase 3BayerNCT02084628Written as Gadoxetate disodium (Eovist/Primovist, BAY86-4873)
- Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive DiagnosisCompletedPhase 4Sara VareaNCT01575574Written as GADOXETIC ACID
- Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer DiagnosisStatus unknownPhase 4National Taiwan University HospitalNCT01956409Written as Magnevist
- MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver CancerCompletedPhase 1University of Southern CaliforniaNCT02578602Written as Gadoxetate Disodium
- 24hr Imaging Of HCC After EOVISTWithdrawnEarly Phase 1Massachusetts General HospitalNCT01968629Written as Eovist
- Primovist / Eovist in Renally Impaired PatientsCompletedPhase 4BayerNCT00908596Written as Gadoxetic acid disodium (Primovist, BAY86-4873)
- Efficacy and Safety of Primovist in Chinese PatientsCompletedPhase 3BayerNCT00526188Written as Gadoxetic Acid Disodium (Primovist, BAY86-4873)
- Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal ArteriesCompletedPhase 3BayerNCT00310557Written as Gadopentetate dimeglumine (Magnevist)
- Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal ArteriesCompletedPhase 3BayerNCT00309075Written as Gadopentetate dimeglumine (Magnevist)
- Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral BranchesCompletedPhase 3BayerNCT00310609Written as Gadopentetate dimeglumine (Magnevist)
- Depiction of Delayed Enhancement in Patients With Documented Myocardial InfarctionCompletedPhase 2BayerNCT00310544Written as Magnevist (Gadopentetate dimeglumine, BAY86-4882)
- Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain MetastasisCompletedPhase 3BayerNCT00681551Written as Magnevist (SH L 451A)
See all 22 studies that test Gadolinium DTPA →
As the comparator · 2 — what is tested is compared with Gadolinium DTPA
- Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese PatientsCompletedPhase 3BayerNCT00395460Written as Magnevist
- Crossover Study With MultiHance vs a Comparator for Peripheral MRACompletedPhase 3Bracco Diagnostics, IncNCT00408083Written as Magnevist
Codes
What other systems call Gadolinium DTPA · ClinicalTrials.gg INT008714
- MeSH (NLM) D019786Gadolinium DTPAOne source NLM
- UNII (FDA) K2I13DR72LGADOPENTETIC ACIDConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019786 | Gadolinium DTPA | One source NLM |
| UNII (FDA) | K2I13DR72L | GADOPENTETIC ACID | Confirmed FDA, NLM |
Also registered as gadopentetate dimeglumine (UNII RH248G8V27 · RxNorm 25486).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.